Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corneal collagen refers to the collagen fibrils found in the corneal stroma, the thick, transparent middle layer of the cornea. These fibrils are predominantly composed of type I collagen, with substantial amounts of type V collagen coassembled into heterotypic fibrils; additional minor types include VI, XII, XIII, XIV, and XXIV collagen[5][7]. The unique physical and optical properties of the cornea—transparency, curvature, and biomechanical strength—result from the highly regular spacing, uniform diameter (about 25–30 nm), and precise lamellar organization of these collagen fibrils[1][5][6][7]. Proteoglycans such as decorin, lumican, keratocan, and mimecan interact closely with corneal collagen to maintain correct fibril structure and spacing, which is essential for corneal clarity[1][5]. Abnormalities or mutations in genes encoding corneal collagen or associated proteins can cause diseases such as corneal opacity and cornea plana[1][5]. Although the term “corneal collagen” is well defined histologically and biochemically within ophthalmology and structural biology, it is not a single molecular target, receptor, or drug target; rather, it refers to a tissue-level matrix component composed of several collagen subtypes[1][5][7]. Thus, it is not appropriate to consider “corneal collagen” as a canonical molecular target, and there is no official abbreviation or dedicated drug interacting with “corneal collagen” as a whole. Instead, individual collagen types (e.g., type I collagen, type V collagen) are sometimes considered as targets in therapeutic research or interventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal collagen.